These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 29931340)

  • 1. Prediction of inactive disease in juvenile idiopathic arthritis: a multicentre observational cohort study.
    van Dijkhuizen EHP; Aidonopoulos O; Ter Haar NM; Pires Marafon D; Magni-Manzoni S; Ioannidis YE; Putignani L; Vastert SJ; Malattia C; De Benedetti F; Martini A
    Rheumatology (Oxford); 2018 Oct; 57(10):1752-1760. PubMed ID: 29931340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study.
    Oen K; Tucker L; Huber AM; Miettunen P; Scuccimarri R; Campillo S; Cabral DA; Feldman BM; Tse S; Chédeville G; Spiegel L; Schneider R; Lang B; Ellsworth J; Ramsey S; Dancey P; Silverman E; Chetaille AL; Cameron B; Johnson N; Dorval J; Petty RE; Duffy KW; Boire G; Haddad E; Houghton K; Saint-Cyr C; Turvey SE; Benseler S; Cheang M; Yeung RS; Duffy CM
    Arthritis Rheum; 2009 Aug; 61(8):1077-86. PubMed ID: 19644903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children's Health, Russia.
    Alexeeva EI; Namazova-Baranova LS; Bzarova TM; Valieva SI; Denisova RV; Sleptsova TV; Isaeva KB; Chomahidze AM; Taibulatov NI; Fetisova AN; Karaseva AV; Baranov AA
    Pediatr Rheumatol Online J; 2017 Jun; 15(1):51. PubMed ID: 28615036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and associated inflammatory biomarker features predictive of short-term outcomes in non-systemic juvenile idiopathic arthritis.
    Rezaei E; Hogan D; Trost B; Kusalik AJ; Boire G; Cabral DA; Campillo S; Chédeville G; Chetaille AL; Dancey P; Duffy C; Watanabe Duffy K; Gordon J; Guzman J; Houghton K; Huber AM; Jurencak R; Lang B; Morishita K; Oen KG; Petty RE; Ramsey SE; Scuccimarri R; Spiegel L; Stringer E; Taylor-Gjevre RM; Tse SML; Tucker LB; Turvey SE; Tupper S; Yeung RSM; Benseler S; Ellsworth J; Guillet C; Karananayake C; Muhajarine N; Roth J; Schneider R; Rosenberg AM
    Rheumatology (Oxford); 2020 Sep; 59(9):2402-2411. PubMed ID: 31919503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease.
    Ravelli A; Felici E; Magni-Manzoni S; Pistorio A; Novarini C; Bozzola E; Viola S; Martini A
    Arthritis Rheum; 2005 Mar; 52(3):826-32. PubMed ID: 15751057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of rheumatoid arthritis disease activity measures and juvenile arthritis disease activity scores in polyarticular-course juvenile idiopathic arthritis: Analysis of their ability to classify the American College of Rheumatology pediatric measures of response and the preliminary criteria for flare and inactive disease.
    Ringold S; Bittner R; Neogi T; Wallace CA; Singer NG
    Arthritis Care Res (Hoboken); 2010 Aug; 62(8):1095-102. PubMed ID: 20506561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiome Analytics of the Gut Microbiota in Patients With Juvenile Idiopathic Arthritis: A Longitudinal Observational Cohort Study.
    van Dijkhuizen EHP; Del Chierico F; Malattia C; Russo A; Pires Marafon D; Ter Haar NM; Magni-Manzoni S; Vastert SJ; Dallapiccola B; Prakken B; Martini A; De Benedetti F; Putignani L;
    Arthritis Rheumatol; 2019 Jun; 71(6):1000-1010. PubMed ID: 30592383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ankle arthritis predicts polyarticular disease course and unfavourable outcome in children with juvenile idiopathic arthritis.
    Esbjörnsson AC; Aalto K; Broström EW; Fasth A; Herlin T; Nielsen S; Nordal E; Peltoniemi S; Rygg M; Zak M; Berntson L;
    Clin Exp Rheumatol; 2015; 33(5):751-7. PubMed ID: 26213158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.
    Spârchez M; Miu N; Bolba C; Iancu M; Spârchez Z; Rednic S
    Clin Rheumatol; 2016 Mar; 35(3):601-7. PubMed ID: 25994613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
    Otten MH; Anink J; Prince FH; Twilt M; Vastert SJ; ten Cate R; Hoppenreijs EP; Armbrust W; Gorter SL; van Pelt PA; Kamphuis SS; Dolman KM; Swart JF; van den Berg JM; Koopman-Keemink Y; van Rossum MA; Wulffraat NM; van Suijlekom-Smit LW
    Ann Rheum Dis; 2015 Jul; 74(7):1379-86. PubMed ID: 24641940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort.
    Guzman J; Oen K; Huber AM; Watanabe Duffy K; Boire G; Shiff N; Berard RA; Levy DM; Stringer E; Scuccimarri R; Morishita K; Johnson N; Cabral DA; Rosenberg AM; Larché M; Dancey P; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Houghton K; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey SE; Bruns A; Roth J; Campillo S; Benseler S; Chédeville G; Schneider R; Tse SM; Bolaria R; Gross K; Feldman B; Feldman D; Cameron B; Jurencak R; Dorval J; LeBlanc C; St Cyr C; Gibbon M; Yeung RS; Duffy CM; Tucker LB;
    Ann Rheum Dis; 2016 Jun; 75(6):1092-8. PubMed ID: 25985972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding specific 10-joint Juvenile Arthritis Disease Activity Score (JADAS10) and clinical JADAS10 cut-off values for disease activity levels in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study.
    Backström M; Tynjälä P; Ylijoki H; Aalto K; Kärki J; Pohjankoski H; Keskitalo P; Sard S; Hietanen M; Lehto H; Kauko T; Vähäsalo P
    Rheumatology (Oxford); 2016 Apr; 55(4):615-23. PubMed ID: 26447164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical profile and juvenile arthritis damage index in children with juvenile idiopathic arthritis: A study from a tertiary care center in south India.
    Menon NVB; Peethambaran G; Puthiyapurayil AT; Nambudakath C; Arakkal R
    Int J Rheum Dis; 2018 Apr; 21(4):871-879. PubMed ID: 27309679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early predictors of prognosis in juvenile idiopathic arthritis: a systematic literature review.
    van Dijkhuizen EH; Wulffraat NM
    Ann Rheum Dis; 2015 Nov; 74(11):1996-2005. PubMed ID: 24962873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis.
    Felici E; Novarini C; Magni-Manzoni S; Pistorio A; Magnani A; Bozzola E; Buoncompagni A; Martini A; Ravelli A
    J Rheumatol; 2005 Sep; 32(9):1805-10. PubMed ID: 16142881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble interleukin-2 receptor serum levels facilitate prediction of relapses in subgroups of patients with juvenile idiopathic arthritis.
    Ziegler L; Fuehner S; Kessel C; Hinze C; Klotsche J; Niewerth M; Minden K; Foell D
    Rheumatology (Oxford); 2022 Nov; 61(12):4975-4984. PubMed ID: 35325053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
    van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
    Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort.
    Guzman J; Oen K; Tucker LB; Huber AM; Shiff N; Boire G; Scuccimarri R; Berard R; Tse SM; Morishita K; Stringer E; Johnson N; Levy DM; Duffy KW; Cabral DA; Rosenberg AM; Larché M; Dancey P; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Houghton K; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey S; Bruns A; Campillo S; Benseler S; Chédeville G; Schneider R; Yeung R; Duffy CM;
    Ann Rheum Dis; 2015 Oct; 74(10):1854-60. PubMed ID: 24842571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile idiopathic arthritis profile in Turkish children.
    Yilmaz M; Kendirli SG; Altintas DU; Karakoc GB; Inal A; Kilic M
    Pediatr Int; 2008 Apr; 50(2):154-8. PubMed ID: 18353049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of response to etanercept in polyarticular-course juvenile idiopathic arthritis.
    Geikowski T; Becker I; Horneff G;
    Rheumatology (Oxford); 2014 Jul; 53(7):1245-9. PubMed ID: 24599916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.